Market revenue in 2021 | USD 15.7 million |
Market revenue in 2028 | USD 19.5 million |
Growth rate | 3.1% (CAGR from 2021 to 2028) |
Largest segment | Accu-chek inform ii |
Fastest growing segment | CareSens Expert Plus |
Historical data | 2016 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | I-STAT, CareSens Expert Plus, Accu-Chek Inform II, StatStrip, HemoCue |
Key market players worldwide | Roche Holding AG ADR, Abbott Laboratories, Nova Biomedical, Bayer AG, Danaher Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to network point-of-care glucose testing market will help companies and investors design strategic landscapes.
Accu-chek inform ii was the largest segment with a revenue share of 50.96% in 2021. Horizon Databook has segmented the Mexico network point-of-care glucose testing market based on i-stat, caresens expert plus, accu-chek inform ii, statstrip, hemocue covering the revenue growth of each sub-segment from 2016 to 2028.
The POC testing solutions in Mexican Association of Clinical Laboratory Sciences (CMCLC) are witnessing various improvements in terms of adoption and awareness. Self-monitoring devices and emergency departments have been witnessing greater demand in recent years, which offers lucrative growth opportunities to POC glucose testing product manufacturers in the country.
However, main barriers to market entry include higher cost of POC testing devices, restrictive government policies & their implementation, and higher adoption of sophisticated POC testing devices across intensive care units in comparison with other medical settings.
In spite of increasing adoption of POC devices in emergency units, lack of collaborative authorities that can aid in improving quality of management is expected to hinder the market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico network point-of-care glucose testing market , including forecasts for subscribers. This country databook contains high-level insights into Mexico network point-of-care glucose testing market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account